About this trial
Acute kidney injury (AKI) affects more than 50% of patients admitted to the intensive care unit. The most common underlying cause is sepsis. Severe AKI in combination with sepsis is associated with high mortality. The mechanisms for sepsis-induced AKI are largely unknown. Our hypothesis is that the inflammatory response to an infection cause collateral damage to host tissue and contributes to the development of AKI. In this study we want to investigate the presence of novel inflammatory mediators in patients with sepsis, patients subjected to major surgery (sterile inflammation) and non-inflamed patients and correlate their levels with the risk for AKI.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
with septic shock or
post major surgery or
after intoxication with a chemical compund
Disqualifiers
Pregnancy or
Breast feeding or
Chronic kidney disease or
intoxication with nephrotoxic compund or
Trial population
Patients subjected to major surgery or intensive care
Trial design
Cohort
Prospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Histones
Correlation between levels of histones and degree of acute kidney injury
Secondary outcomes
Other inflammtory mediators
Correlation between levels of other inflammtory mediators and degree of acute kidney injury
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Uppsala University
Lead sponsor
Maastricht University
Collaborator